Moderna says on track to report late-stage COVID-19 vaccine data next month

[perugu_vada]

Moderna Inc (MRNA.O) is on track to report early data from a late-stage trial of its COVID-19 vaccine candidate next month, the company said on Thursday, offering the clearest timeline yet on when the world will know whether the vaccine is effective.

The company, one of the front-runners in the global race to produce a vaccine, said its independent data monitoring committee is expected to conduct an interim review of its ongoing 30,000-volunteer late-stage trial in November.

Moderna said it expects two-month safety data, as required by the U.S. Food and Drug Administration, in the second half of November, after which it will file for an emergency use authorization.

[DummyVariable]

94% success

Emergency approval filed. Stock up 12% premarket

[DummyVariable]

25 points up

[LadiesTailor]

Nice 

[shaw183]

7 hours ago, DummyVariable said:

94% success

Emergency approval filed. Stock up 12% premarket

stocks penchadinke evani anipistundi.. epatlo vaccine ochela kanapadadam ledu 

[Dippindots]

9 minutes ago, shaw183 said:

stocks penchadinke evani anipistundi.. epatlo vaccine ochela kanapadadam ledu 

why do you think so?

we have first hand information from Frontline workers.